glp-1 receptor agonist mechanism of action Frontiers A Closer Look at the

[DOI] [PMC free article] [PubMed] [Google Scholar] 18.Wilson J

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture

* Axxam hereby acknowledges that the NCI-H716 cell line (ATCC Ref

The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis

persistent, severe abdominal pain) Hypersensitivity to DPP-4 inhibitors in the past Pregnancy/breastfeeding Some DPP-4 inhibitors are contraindicated at certain thresholds of renal impairment (see Table 2 ) Some DPP-4 inhibitors are contraindicated in hepatic impairment (see Table 3 ) Type 1 diabetes Diabetic ketoacidosis Cautions History of pancreatitis Moderate heart failure (saxagliptin only, due to limited experience) Severe heart failure (saxagliptin and vildagliptin, due to limited experience) Some DPP-4 inhibitors are cautioned at certain thresholds of renal impairment, and dose reductions may be required (see Table 2 ) Drug interactions No significant interactions have been reported between DPP-4 inhibitors and any other drugs

Given the vast number of incretin-based medications under development, mainly aiming at higher efficacy in body weight reduction, one may overlook that adherence to, and persistence of, therapy with GLP-1RAs in real-world studies is relatively low (18, 126)